메뉴 건너뛰기




Volumn 15, Issue 4, 2012, Pages 374-379

Evaluating prostate cancer mortality and competing risks of death in patients with localized prostate cancer using a comprehensive nomogram

Author keywords

comorbidities; competing risks; nomogram; radiation therapy; radical prostatectomy

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; CANCER GROWTH; CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER RISK; CANCER STAGING; CAUCASIAN; COMORBIDITY; CONTROLLED STUDY; DEATH; HAZARD ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; RISK ASSESSMENT; RISK FACTOR;

EID: 84869232596     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/pcan.2012.21     Document Type: Article
Times cited : (27)

References (33)
  • 1
    • 80051580618 scopus 로고    scopus 로고
    • Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths
    • Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011; 61: 212-236.
    • (2011) CA Cancer J Clin , vol.61 , pp. 212-236
    • Siegel, R.1    Ward, E.2    Brawley, O.3    Jemal, A.4
  • 2
    • 70349140531 scopus 로고    scopus 로고
    • Outcomes of localized prostate cancer following conservative management
    • Lu-Yao GL, Albertsen PC, Moore DF, Shih W, Lin Y, DiPaola RS et al. Outcomes of localized prostate cancer following conservative management. JAMA 2009; 302: 1202-1209.
    • (2009) JAMA , vol.302 , pp. 1202-1209
    • Lu-Yao, G.L.1    Albertsen, P.C.2    Moore, D.F.3    Shih, W.4    Lin, Y.5    Dipaola, R.S.6
  • 4
    • 77649170747 scopus 로고    scopus 로고
    • The 2010 NCCN clinical practice guidelines in oncology on prostate cancer
    • Mohler JL. The 2010 NCCN clinical practice guidelines in oncology on prostate cancer. J Natl Compr Canc Netw 2010; 8: 145.
    • (2010) J Natl Compr Canc Netw , vol.8 , pp. 145
    • Mohler, J.L.1
  • 6
    • 78649362120 scopus 로고    scopus 로고
    • EAU guidelines on prostate cancer. Part 1: Screening, diagnosis, and treatment of clinically localised disease
    • Heidenreich A, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V et al. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Urol 2011; 59: 61-71.
    • (2011) Eur Urol , vol.59 , pp. 61-71
    • Heidenreich, A.1    Bellmunt, J.2    Bolla, M.3    Joniau, S.4    Mason, M.5    Matveev, V.6
  • 9
    • 33745650451 scopus 로고    scopus 로고
    • Greater influence of age than co-morbidity on primary treatment and complications of prostate cancer patients: An in-depth population-based study
    • DOI 10.1038/sj.pcan.4500868, PII 4500868
    • Houterman S, Janssen-Heijnen ML, Verheij CD, Kil PJ, van den Berg HA, Coebergh JW. Greater influence of age than co-morbidity on primary treatment and complications of prostate cancer patients: an in-depth population-based study. Prostate Cancer Prostatic Dis 2006; 9: 179-184. (Pubitemid 43970968)
    • (2006) Prostate Cancer and Prostatic Diseases , vol.9 , Issue.2 , pp. 179-184
    • Houterman, S.1    Janssen-Heijnen, M.L.G.2    Verheij, C.D.G.W.3    Kil, P.J.M.4    Van Den Berg, H.A.5    Coebergh, J.W.6
  • 10
    • 39749132273 scopus 로고    scopus 로고
    • Is there an optimal comorbidity index for prostate cancer?
    • DOI 10.1002/cncr.23269
    • Alibhai SM, Leach M, Tomlinson GA, Krahn MD, Fleshner NE, Naglie G. Is there an optimal comorbidity index for prostate cancer? Cancer 2008; 112: 1043-1050. (Pubitemid 351304588)
    • (2008) Cancer , vol.112 , Issue.5 , pp. 1043-1050
    • Alibhai, S.M.H.1    Leach, M.2    Tomlinson, G.A.3    Krahn, M.D.4    Fleshner, N.E.5    Naglie, G.6
  • 11
    • 77957579281 scopus 로고    scopus 로고
    • Predictive and prognostic models in radical prostatectomy candidates: A critical analysis of the literature
    • Lughezzani G, Briganti A, Karakiewicz PI, Kattan MW, Montorsi F, Shariat SF et al. Predictive and prognostic models in radical prostatectomy candidates: a critical analysis of the literature. Eur Urol 2010; 58: 687-700.
    • (2010) Eur Urol , vol.58 , pp. 687-700
    • Lughezzani, G.1    Briganti, A.2    Karakiewicz, P.I.3    Kattan, M.W.4    Montorsi, F.5    Shariat, S.F.6
  • 13
    • 1642412636 scopus 로고    scopus 로고
    • Long-term survival probability in men with clinically localized prostate cancer: A case-control, propensity modeling study stratified by race, age, treatment and comorbidities
    • DOI 10.1097/01.ju.0000117975.40782.95
    • Tewari A, Johnson CC, Divine G, Crawford ED, Gamito EJ, Demers R et al. Longterm survival probability in men with clinically localized prostate cancer: a casecontrol, propensity modeling study stratified by race, age, treatment and comorbidities. J Urol 2004; 171: 1513-1519. (Pubitemid 38365408)
    • (2004) Journal of Urology , vol.171 , Issue.4 , pp. 1513-1519
    • Tewari, A.1    Johnson, C.C.2    Divine, G.3    Crawford, E.D.4    Gamito, E.J.5    Demers, R.6    Menon, M.7
  • 14
    • 0030297775 scopus 로고    scopus 로고
    • The CaPSURE database: A methodology for clinical practice and research in prostate cancer
    • DOI 10.1016/S0090-4295(96)00226-9, PII S0090429596002269
    • Lubeck DP, Litwin MS, Henning JM, Stier DM, Mazonson P, Fisk R et al. The CaPSURE database: a methodology for clinical practice and research in prostate cancer. CaPSURE Research Panel. Cancer of the Prostate Strategic Urologic Research Endeavor. Urology 1996; 48: 773-777. (Pubitemid 26398700)
    • (1996) Urology , vol.48 , Issue.5 , pp. 773-777
    • Lubeck, D.P.1    Litwin, M.S.2    Henning, J.M.3    Stier, D.M.4    Mazonson, P.5    Fisk, R.6    Carroll, P.R.7
  • 15
    • 67449126769 scopus 로고    scopus 로고
    • Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis
    • Cooperberg MR, Broering JM, Carroll PR. Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis. J Natl Cancer Inst 2009; 101: 878-887.
    • (2009) J Natl Cancer Inst , vol.101 , pp. 878-887
    • Cooperberg, M.R.1    Broering, J.M.2    Carroll, P.R.3
  • 18
    • 84869206672 scopus 로고    scopus 로고
    • National Vital Statistics Report (NVSR)
    • US National Center for Health Statistics, 24 April
    • US National Center for Health Statistics. National Vital Statistics Report (NVSR) Deaths: Final Data for 2006. Vol. 67, No. 14, 24 April 2009.
    • (2009) Deaths: Final Data for 2006 , vol.67 , Issue.14
  • 19
    • 1542532754 scopus 로고    scopus 로고
    • A proportional hazards model for the subdistrituion of a competing risk
    • Fine JP, Gray RJ. A proportional hazards model for the subdistrituion of a competing risk. J Am Stat Assoc 1999; 94: 496-509.
    • (1999) J Am Stat Assoc , vol.94 , pp. 496-509
    • Fine, J.P.1    Gray, R.J.2
  • 20
    • 48349127426 scopus 로고    scopus 로고
    • External validation of University of California, San Francisco, Cancer of the Prostate Risk Assessment score
    • Zhao KH, Hernandez DJ, Han M, Humphreys EB, Mangold LA, Partin AW. External validation of University of California, San Francisco, Cancer of the Prostate Risk Assessment score. Urology 2008; 72: 396-400.
    • (2008) Urology , vol.72 , pp. 396-400
    • Zhao, K.H.1    Hernandez, D.J.2    Han, M.3    Humphreys, E.B.4    Mangold, L.A.5    Partin, A.W.6
  • 22
    • 29144465604 scopus 로고    scopus 로고
    • Predicting life expectancy in men with clinically localized prostate cancer
    • DOI 10.1016/S0022-5347(05)00018-2, PII S0022534705000182
    • Cowen ME, Halasyamani LK, Kattan MW. Predicting life expectancy in men with clinically localized prostate cancer. J Urol 2006; 175: 99-103. (Pubitemid 41797102)
    • (2006) Journal of Urology , vol.175 , Issue.1 , pp. 99-103
    • Cowen, M.E.1    Halasyamani, L.K.2    Kattan, M.W.3
  • 23
    • 79954428605 scopus 로고    scopus 로고
    • Impact of comorbidity on survival among men with localized prostate cancer
    • Albertsen PC, Moore DF, Shih W, Lin Y, Li H, Lu-Yao GL. Impact of comorbidity on survival among men with localized prostate cancer. J Clin Oncol 2011; 29: 1335-1341.
    • (2011) J Clin Oncol , vol.29 , pp. 1335-1341
    • Albertsen, P.C.1    Moore, D.F.2    Shih, W.3    Lin, Y.4    Li, H.5    Lu-Yao, G.L.6
  • 24
    • 80053339922 scopus 로고    scopus 로고
    • Cancer-specific and other-cause mortality after radical prostatectomy versus observation in patients with prostate cancer: Competing-risks analysis of a large North American population-based cohort
    • Abdollah F, Sun M, Schmitges J, Tian Z, Jeldres C, Briganti A et al. Cancer-specific and other-cause mortality after radical prostatectomy versus observation in patients with prostate cancer: competing-risks analysis of a large North American population-based cohort. Eur Urol 2011; 60: 920-930.
    • (2011) Eur Urol , vol.60 , pp. 920-930
    • Abdollah, F.1    Sun, M.2    Schmitges, J.3    Tian, Z.4    Jeldres, C.5    Briganti, A.6
  • 25
    • 70349313376 scopus 로고    scopus 로고
    • Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era
    • Stephenson AJ, Kattan MW, Eastham JA, Bianco Jr FJ, Yossepowitch O, Vickers AJ et al. Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era. J Clin Oncol 2009; 27: 4300-4305.
    • (2009) J Clin Oncol , vol.27 , pp. 4300-4305
    • Stephenson, A.J.1    Kattan, M.W.2    Eastham, J.A.3    Bianco Jr., F.J.4    Yossepowitch, O.5    Vickers, A.J.6
  • 26
    • 0029044623 scopus 로고
    • Selecting a patient characteristics index for the prediction of medical outcomes using administrative claims data
    • Melfi C, Holleman E, Arthur D, Katz B. Selecting a patient characteristics index for the prediction of medical outcomes using administrative claims data. J Clin Epidemiol 1995; 48: 917-926.
    • (1995) J Clin Epidemiol , vol.48 , pp. 917-926
    • Melfi, C.1    Holleman, E.2    Arthur, D.3    Katz, B.4
  • 27
    • 0030294149 scopus 로고    scopus 로고
    • Comorbid Illness is Associated with Survival and Length of Hospital Stay in Patients with Chronic Disability: A Prospective Comparison of Three Comorbidity Indices
    • Rochon PA, Katz JN, Morrow LA, McGlinchey-Berroth R, Ahlquist MM, Sarkarati M et al. Comorbid illness is associated with survival and length of hospital stay in patients with chronic disability. A prospective comparison of three comorbidity indices. Med Care 1996; 34: 1093-1101. (Pubitemid 126433208)
    • (1996) Medical Care , vol.34 , Issue.11 , pp. 1093-1101
    • Rochon, P.A.1    Katz, J.N.2    Morrow, L.A.3    Mcglinchey-Berroth, R.4    Ahlquist, M.M.5    Sarkarati, M.6    Minaker, K.L.7
  • 28
    • 80053920100 scopus 로고    scopus 로고
    • Comorbidity and competing risks for mortality in men with prostate cancer
    • (E-pub ahead of print)
    • Daskivich TJ, Chamie K, Kwan L, Labo J, Dash A, Greenfield S et al. Comorbidity and competing risks for mortality in men with prostate cancer. Cancer 2011 (E-pub ahead of print).
    • (2011) Cancer
    • Daskivich, T.J.1    Chamie, K.2    Kwan, L.3    Labo, J.4    Dash, A.5    Greenfield, S.6
  • 29
    • 78449267553 scopus 로고    scopus 로고
    • Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer
    • Cooperberg MR, Vickers AJ, Broering JM, Carroll PR. Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer. Cancer 2010; 116: 5226-5234.
    • (2010) Cancer , vol.116 , pp. 5226-5234
    • Cooperberg, M.R.1    Vickers, A.J.2    Broering, J.M.3    Carroll, P.R.4
  • 30
    • 78650251130 scopus 로고    scopus 로고
    • A competing-risks analysis of survival after alternative treatment modalities for prostate cancer patients: 1988-2006
    • Abdollah F, Sun M, Thuret R, Jeldres C, Tian Z, Briganti A et al. A competing-risks analysis of survival after alternative treatment modalities for prostate cancer patients: 1988-2006. Eur Urol 2011; 59: 88-95.
    • (2011) Eur Urol , vol.59 , pp. 88-95
    • Abdollah, F.1    Sun, M.2    Thuret, R.3    Jeldres, C.4    Tian, Z.5    Briganti, A.6
  • 31
    • 69249229866 scopus 로고    scopus 로고
    • Hormonal therapy use for prostate cancer and mortality in men with coronary artery disease-induced congestive heart failure or myocardial infarction
    • Nanda A, Chen MH, Braccioforte MH, Moran BJ, D'Amico AV. Hormonal therapy use for prostate cancer and mortality in men with coronary artery disease-induced congestive heart failure or myocardial infarction. JAMA 2009; 302: 866-873.
    • (2009) JAMA , vol.302 , pp. 866-873
    • Nanda, A.1    Chen, M.H.2    Braccioforte, M.H.3    Moran, B.J.4    D'Amico, A.V.5
  • 33
    • 77949898163 scopus 로고    scopus 로고
    • Time trends and local variation in primary treatment of localized prostate cancer
    • Cooperberg MR, Broering JM, Carroll PR. Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol 2010; 28: 1117-1123.
    • (2010) J Clin Oncol , vol.28 , pp. 1117-1123
    • Cooperberg, M.R.1    Broering, J.M.2    Carroll, P.R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.